Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy by von Drygalski, Annette, Gomez, Esteban, Giermasz, Adam, Castaman, Giancarlo, Key, Nigel S., Lattimore, Susan U., Leebeek, Frank W. G., Miesbach, Wolfgang A., Recht, Michael, Gut, Robert, Dolmetsch, Ricardo, Monahan, Paul E., Le Quellec, Sandra, Pipe, Steven W.

Get full text

Patient and Family Engagement during Treatment Change to Emicizumab at a Hemophilia Treatment Center by Lattimore, Susan U, Hofstetter, Madolyn T

Get full text

Telephone assessment of stroke outcome is reliable by Merino, José G, Lattimore, Susan U, Warach, Steven

Get full text

Etranacogene Dezaparvovec (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial by von Drygalski, Annette, Giermasz, Adam, Castaman, Giancarlo, Key, Nigel S., Lattimore, Susan U., Leebeek, Frank W.G., Miesbach, Wolfgang A., Recht, Michael, Gomez, Esteban, Gut, Robert, Pipe, Steven W.

Get full text

Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome by Sidonio, Robert F., Cheng, Dunlei, Guelcher, Christine, Journeycake, Janna M., Lattimore, Susan U, Takemoto, Clifford, Tarantino, Michael D., Watson, Crystal, Neufeld, Ellis J., Fedor, Carol

Get full text

One Year Data from a Phase 2b Trial of AMT-061 (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B by Pipe, Steven, Giermasz, Adam, Castaman, Giancarlo, Key, Nigel S., Lattimore, Susan U, Leebeek, Frank, Miesbach, Wolfgang, Recht, Michael, Gomez, Esteban, Long, Alison, Gut, Robert, von Drygalski, Annette

Get full text

Dosing, Patient Satisfaction and Other Patient-Reported Outcomes after Switching to Rurioctocog Alfa Pegol in Athn 2: A Longitudinal, Observational Study of Previously Treated Hemo... by Journeycake, Janna M., Recht, Michael, Guelcher, Christine, Neufeld, Ellis J., Ragni, Margaret V., Sidonio, Robert F., Takemoto, Cliff, Tarantino, Michael D, Cheng, Dunlei, Lattimore, Susan U., Caicedo, Jorge, Denne, Michael

Get full text

First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe... by Pipe, Steven W., Recht, Michael, Key, Nigel S., Leebeek, Frank W.G., Castaman, Giancarlo, Lattimore, Susan U., Van Der Valk, Paul, Peerlinck, Kathelijne, Coppens, Michiel, O'Connell, Niamh, Pasi, John, Kampmann, Peter, Meijer, Karina, von Drygalski, Annette, Young, Guy, Hermans, Cedric, Astermark, Jan, Klamroth, Robert, Lemons, Richard S., Visweshwar, Nathan, Crary, Shelley, Kazmi, Rashid, Symington, Emily, Escobar, Miguel A., Gomez, Esteban, Kruse-Jarres, Rebecca, Kotowski, Adam, Quon, Doris, Wang, Michael, Wheeler, Allison P., Sawyer, Eileen K, Verweij, Stephanie, Colletta, Valerie, Bajma, Naghmana, Gut, Robert, Miesbach, Wolfgang A.

Get full text

Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital Stroke Center experience by Lattimore, Susan Unipan, Chalela, Julio, Davis, Lisa, DeGraba, Thomas, Ezzeddine, Mustapha, Haymore, Joseph, Nyquist, Paul, Baird, Alison E, Hallenbeck, John, Warach, Steven

Get full text